Chemoinformaics analysis of 4-hydroxycitrulline
| Molecular Weight | 191.187 | nRot | 5 |
| Heavy Atom Molecular Weight | 178.083 | nRig | 2 |
| Exact Molecular Weight | 191.091 | nRing | 0 |
| Solubility: LogS | -0.578 | nHRing | 0 |
| Solubility: LogP | -3.47 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 26 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 13 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 6 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 3 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 0 |
| nHA | 4 | APOL | 25.1963 |
| nHD | 5 | BPOL | 14.2077 |
| QED | 0.336 |
| Synth | 3.262 |
| Natural Product Likeliness | 0.59 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0 |
| Pgp-sub | 0.825 |
| HIA | 0.021 |
| CACO-2 | -6.405 |
| MDCK | 0.00309577 |
| BBB | 0.586 |
| PPB | 0.0675527 |
| VDSS | 0.361 |
| FU | 0.910452 |
| CYP1A2-inh | 0.005 |
| CYP1A2-sub | 0.019 |
| CYP2c19-inh | 0.045 |
| CYP2c19-sub | 0.047 |
| CYP2c9-inh | 0.056 |
| CYP2c9-sub | 0.081 |
| CYP2d6-inh | 0.016 |
| CYP2d6-sub | 0.202 |
| CYP3a4-inh | 0.006 |
| CYP3a4-sub | 0.01 |
| CL | 3.796 |
| T12 | 0.501 |
| hERG | 0.016 |
| Ames | 0.054 |
| ROA | 0.012 |
| SkinSen | 0.154 |
| Carcinogencity | 0.013 |
| EI | 0.036 |
| Respiratory | 0.12 |
| NR-Aromatase | 0.002 |
| Antiviral | No |
| Prediction | 0.862379 |